[1] IAIN A MURRAY. Suppression of cytokine-mediated complement factor gene expression through selective activation of the Ah receptor with 3’,4’-dimethoxy-α-naphthoflavone.[J]. Molecular Pharmacology, 2011, 79 3: 508-519. DOI:
10.1124/mol.110.069369[2] GITANJALI A NARAYANAN. Selective aryl hydrocarbon receptor modulator-mediated repression of CD55 expression induced by cytokine exposure.[J]. Journal of Pharmacology and Experimental Therapeutics, 2012, 342 2: 345-355. DOI:
10.1124/jpet.112.193482[3] MARK P LABRECQUE. Distinct roles for aryl hydrocarbon receptor nuclear translocator and ah receptor in estrogen-mediated signaling in human cancer cell lines.[J]. PLoS ONE, 2012: e29545. DOI:
10.1371/journal.pone.0029545